Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
74.19
+0.80 (1.09%)
Jul 16, 2025, 2:45 PM CST
82.15%
Market Cap33.04B
Revenue (ttm)2.42B
Net Income (ttm)101.52M
Shares Out445.34M
EPS (ttm)0.21
PE Ratio325.49
Forward PE137.41
Dividendn/a
Ex-Dividend Daten/a
Volume8,361,018
Average Volume8,307,614
Open74.72
Previous Close73.39
Day's Range73.59 - 76.60
52-Week Range31.07 - 87.97
Beta0.82
RSI66.35
Earnings DateAug 29, 2025

About Sinocelltech Group

Sinocelltech Group Limited, a biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China. The company offers Anpingxi an antibody drug and anti-tumor product; Anjiayin for the treatment of the rare disease hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and mutant strain recombinant protein vaccines SCTV01C and SCTV01E. Its pipeline products include SCT630 used for the treatment of autoimmune diseases; SCT510 for the treatment of ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,277
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.